HIRA gave notice of health insurance benefits for Keytruda and Opdivo
The Health Insurance Review & Assurance Service(President Seung-Taek Kim, HIRA) decided a revision bill for the ‘Details of Health Insurance Benefit Application Standards and Methods for Drugs Prescribed and Used for Cancer Patients,’ which create health insurance benefit standards for Keytruda(g...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.